CHARLES W LUNN
Allopathic & Osteopathic Physicians|Family Medicine OKLAHOMA CITY, OK NPI 1477529535
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine OK Amgen Inc. All categories
General Payments — all program years on this page
$2,009.77
- Category: General Payments
- Program years: PY2018–2024
- Record count: 53
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,202.75 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Travel and Lodging | $834.57 | 2 |
| Food and Beverage | $368.18 | 6 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $1,109.57 | 3 |
| ABBVIE INC. | $23.29 | 1 |
| Mylan Specialty L.P. | $20.94 | 1 |
| GlaxoSmithKline, LLC. | $17.57 | 1 |
| Recor Medical Inc | $17.43 | 1 |
| Novo Nordisk AS | $13.95 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1096935765 | Novo Nordisk Inc | $13.95 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104912377 | ABBVIE INC. | $23.29 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111638826 | Amgen Inc. | $275.00 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111638828 | Amgen Inc. | $281.37 | 02/23/2024 | Travel and Lodging | Undisputed | 01/23/2026 | View at CMS |
| 1111638830 | Amgen Inc. | $553.20 | 02/23/2024 | Travel and Lodging | Undisputed | 01/23/2026 | View at CMS |
| 1116504999 | GlaxoSmithKline, LLC. | $17.57 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1127688077 | Recor Medical Inc | $17.43 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1147348921 | Mylan Specialty L.P. | $20.94 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.